It is found that loss of key genes in TNF signaling, IFN-γ signaling or antigen presentation pathway could enhance cancer cell resistance to CD8+ T cell-mediated killing and weaken the effect of anti-tumor immune response in vivo. This evidence concerns the gene CD8A and cancer.